Kyle Roberts

Kyle Roberts serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions, from requirements definition and market research through solicitation, evaluation, award, and contract administration. He plays a critical role in ensuring compliance with the Federal Acquisition Regulation (FAR) and supports the agency’s mission by delivering essential goods and services through transparent, competitive procurement processes. His portfolio primarily encompasses high-compliance, technical acquisitions in pharmaceutical manufacturing, biological products, and medical instrumentation, often involving complex regulatory and quality assurance requirements. Roberts routinely handles both sealed bidding and negotiated procurements, with a strong emphasis on risk mitigation and regulatory alignment. While specific contractor names are not available, Roberts maintains relationships with a diverse pool of vendors, including large manufacturers with cGMP and FDA-regulated production capabilities, as well as specialized small businesses in life sciences and industrial construction. His contracting approach emphasizes performance-based outcomes, clear statement of work development, and rigorous source selection criteria aligned with technical merit and past performance. He fosters collaborative vendor engagement through pre-solicitation outreach and debriefings, promoting fairness and accountability in the acquisition process. Roberts demonstrates a strong preference for open competition, with 92.9% of his awards issued without set-aside restrictions. However, he consistently supports small business participation, allocating 7.1% of his acquisitions to Total Small Business Set-Asides under FAR 19.5. This reflects a balanced commitment to maximizing competition while ensuring opportunities for qualified small businesses, particularly those capable of meeting stringent manufacturing and quality standards. His primary procurement focus lies in NAICS 325414 (Biological Product Manufacturing) and 325412 (Pharmaceutical Preparation Manufacturing), each accounting for one-third of his portfolio, alongside industrial building construction (236210) and surgical instrument manufacturing (339112). He frequently procures cGMP-compliant pharmaceuticals, biologics, sterile injectables, and specialized medical devices, requiring deep familiarity with FDA regulations, supply chain integrity, and validated manufacturing processes. His expertise extends to managing complex technical requirements in life sciences and healthcare infrastructure.